Teladoc Health
TDOC
679 hedge funds and large institutions have $10B invested in Teladoc Health in 2022 Q1 according to their latest regulatory filings, with 88 funds opening new positions, 256 increasing their positions, 228 reducing their positions, and 131 closing their positions.
12% more repeat investments, than reductions
Existing positions increased: 256 | Existing positions reduced: 228
1.19% less ownership
Funds ownership: 88.05% → 86.85% (-1.2%)
7% less funds holding
Funds holding: 728 → 679 (-49)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
19% less call options, than puts
Call options by funds: $1.1B | Put options by funds: $1.37B
22% less capital invested
Capital invested by funds: $13B → $10B (-$2.91B)
33% less first-time investments, than exits
New positions opened: 88 | Existing positions closed: 131
Top Buyers
| 1 |
BlackRock
New York
|
+$92.6M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$80.3M |
| 3 |
Bank of New York Mellon
New York
|
+$78M |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$45.4M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$39.2M |
Top Sellers
| 1 |
KA
Kinnevik AB
Stockholm,
Sweden
|
-$94.2M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$91.2M |
| 3 |
Parallax Volatility Advisers
San Francisco,
California
|
-$69.1M |
| 4 |
Renaissance Technologies
New York
|
-$62.5M |
| 5 |
DVF
Discovery Value Fund
Singapore
|
-$34.5M |
TDOC Hedge Fund Activity: Q1 2022 in Review
679 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Teladoc Health (TDOC) for Q1 2022, worth a combined $10B — down 22% from $13B a quarter earlier.
Sellers outnumbered buyers: 131 funds closed out of TDOC and 88 opened new positions — a net loss of 43 holders — while 228 trimmed existing stakes and 256 added.
The largest buyer was BlackRock, adding an estimated $92.6M. The largest seller was Kinnevik AB, cutting an estimated $94.2M.
- 679 institutional investors held Teladoc Health (TDOC) as of Q1 2022, down from 728 in Q4 2021.
- Funds reported $10B of Teladoc Health stock for Q1 2022, down 22% quarter-over-quarter.
- 88 funds opened new Teladoc Health positions in Q1 2022 and 131 closed out, a net change of -43 holders.
- The largest Teladoc Health buyer in Q1 2022 was BlackRock, an estimated $92.6M added.
- The largest Teladoc Health seller in Q1 2022 was Kinnevik AB, an estimated $94.2M sold.
Based on aggregated 13F filings for Q1 2022.